Background {#Sec1}
==========

Many cereals such as soybean and wheat contain up to 15% non-starch polysaccharides (NSPs) in their outer or inner cell walls \[[@CR1]\]. Monogastric animals lack enzymes to degrade the cell wall and NSP in these feeds. Thus, these anti-nutritive factors may interfere with digestion, nutrient absorption, and intestinal tract health by encapsuling starch and protein, as well as increase the viscosity of the chymus, which may elevate the proliferation of pathological bacteria in the small intestine and reduce the feed conversion ratio of monogastric livestock species \[[@CR2]--[@CR4]\].

The supplementation of exogenous enzymes such as xylanases and β-glucanases in pig diets may facilitate the hydrolysis of the main NSPs and increase the utilization of available raw materials \[[@CR5], [@CR6]\]. Adding exogenous enzymes to cereal diets improves both nutrient digestibility and growth performance in pigs \[[@CR7], [@CR8]\]. However, the exact molecular mechanisms of NSPEs, particularly in the gastrointestinal (GI) tract, are unknown \[[@CR9]\]. There are several indications that exogenous enzymes may function in the GI tract of animals to aid digestion. The supplementation of NSPEs in the diets could increase the activities of certain types of digestive enzymes in vivo including protease, trypsin, and α-amylase \[[@CR2], [@CR4], [@CR10]\]. These enzymes reduce the degradation of NSPs within the small intestine, thereby decreasing the viscosity of the digesta, which leads to a reduced bacterial load in the gut, especially potential pathogens \[[@CR11]\]. Furthermore, the degradation of NSPs due to the supplementation of NSPEs promotes the higher availability of digestible nutrients such as energy substrates \[[@CR12]\]. Additionally, the intestinal morphological structure and some physiological functions in animals benefit from the improvement of the changing intestinal environment due to the supplementation of NSPEs. Some research demonstrated that intestinal morphologies, including the villus height, the ratio of villus height to crypt depth, and the number of crypts and goblet cells, were changed due to the addition of xylanases alone or multiple enzymes \[[@CR13], [@CR14]\]. In addition to the effects of NSPEs observed on the GI tract, alterations of blood parameters related to the nutrient metabolism were also noted \[[@CR15]\].

Previous studies reported that diet composition affected gene expression in animals \[[@CR9], [@CR16]\]. It is assumed that the improvement of the intestinal environment due to the supplementation of NSPEs in the diet may influence the gene expression and subsequent protein expression of epithelial-cell nutrient transporters in the GI tract mucosa, which has not been studied before. However, RNA editing and numerous options for posttranslational modifications should be taken into account \[[@CR17], [@CR18]\]. Hence, elucidation protein expression is important \[[@CR19]\].

It is impractical to simultaneously measure all protein expression in the GI mucosa by classical method, such as western blotting. More research has yielded high throughput mass spectrometric proteomic technologies that can simultaneously detect hundreds of proteins \[[@CR20], [@CR21]\]. A proteomic analysis of the rat small intestinal proteome showed the presence of previously unrecognized proteins involved in various functions including the absorption and transport of nutrients and the maintenance of cell structure, as well as intestinal molecular chaperones \[[@CR22]\]. There remains a great need to pursue proteomic technology to elucidate the beneficial effects of NSPEs in the GI tract mucosa. Therefore, we utilized a label-based iTRAQ (isobaric tags for relative and absolute quantitation) method, followed by LC-MS/MS, to quantitate proteins that are differentially induced in the small intestinal mucosa of growing pigs supplemented with NSPEs in the diet.

Methods {#Sec2}
=======

Enzyme preparation {#Sec3}
------------------

The NSP enzyme mixture preparation supplemented in the diet was provided by the State Key Laboratory of Animal Nutrition, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences (Beijing, China); the mixture contained 7 × 10^5^ U/g xylanase activity (EC 3.2.1.8), 1 × 10^5^ U/g β-glucanase activity (EC 3.2.1.6), and 9000 U/g cellulase activity (EC 3.2.1.4). The activities of the enzymes used in the present study was measured according the methods mentioned in previous research \[[@CR23]\].

Animals and treatments {#Sec4}
----------------------

Forty-eight crossbred (Duroc × Landrace × Large White) growing pigs had similar initial body weights (39.18 ± 0.98 kg); the pigs were obtained from a commercial farm in Beijing (Shunliang pig farm, Beijing). The pigs were randomly divided into two groups according to their littermates, sex and mean initial body weights with four replicates in each group and six pigs in each replicate (half females and half males). The following two groups were a control group (CTRL, basal diet) and a treatment group (NSPE, basal diet + 0.6% NSP enzymes). The amount of NSPEs supplementation in the present study was based on the previous results from our group \[[@CR24]\]. Both diets were formulated to meet NRC (2012) recommendations (Table [1](#Tab1){ref-type="table"}). All pigs were kept in eight adjacent pens covered in a fermentation bed facility. Feed and water were provided *ad libitum* during the 50 day experimental period. The individual pig weight and feed intake were recorded at the initiation and the termination of the experiment for the measurement of the average daily gain (ADG), average daily feed intake (ADFI) and feed conversion ratio (FCR). All procedures involving animals were evaluated and approved by the Animal Ethics Committee of the Institute of Animal Sciences, Chinese Academy of Agricultural Sciences.Table 1Composition of the basal diet and calculated proximate composition of the dietIngredientsProportion (%)^a^ Corn70.70 Soybean meal19.82 Soybean oil2.10 Wheat bran5.00 Limestone0.51 Calcium hydrophosphate0.56 L-Lysine0.01 Sodium chloride0.30 Premix^b^1.00 Total100Nutrient ME13.65 (MJ/kg) Ether extract (EE)4.82 Crude protein (CP)15.50 Calcium0.50 Total phosphorus0.45 Available phosphorus0.24 Total lysine0.75 Total methionine0.25^a^All data is expressed in g/kg dry weight except for metabolizable energy (ME) in MJ/kg. The amounts of nutrient were estimated based on the NRC 11th ed. swine feedstuff composition table^b^Providing the following (g/kg fresh weight), Vitamin A, 8250 IU; Vitamin D~3~: 825 IU; Vitamin E: 40 IU; Vitamin K~3~, 4.0 mg; Vitamin B~1~, 1.0 mg; Vitamin B~2~, 5.0 mg; Vitamin B~6~, 2.0 mg; Vitamin B~12~, 25 μg; choline chloride, 600 mg; nicotinic acid, 35 mg; folic acid, 2.0 mg; biotin, 4.0 mg; Cu, 50.0 mg; Fe, 80.0 mg; Zn, 100.0 mg; Mn, 25.0 mg; Se, 0.15 mg; I, 0.5 mg

Sample collection {#Sec5}
-----------------

At the end of the experiment (Day 50), all pigs were weighted after 12 h of fasting. One pig per replicate, a total of eight pigs (*n* = 8), were sacrificed by CO~2~ asphyxiation and then exsanguinated. Blood samples were obtained from the cervical vein by syringe before sacrifice. The whole blood was centrifuged at 2000 g for 30 min at 4 °C, followed by centrifugation at 400 g for 10 min at 4 °C. Then, the resulting supernatant was collected as sera samples, which were stored at −20 °C for further analysis. A 20-cm tissue section was rapidly excised at 50% of the length of the small intestine, rinsed with cold phosphate buffer saline, and blotted dry on paper. Mucosa from this small intestine section was sequentially obtained by careful scraping of the mucosal layer using a glass microscope slide as previously described \[[@CR25]\]. Then, the collected mucosal samples were snap-frozen in liquid nitrogen and stored at −80 °C for proteomic analysis.

Serum biochemical analyses {#Sec6}
--------------------------

Important serum biochemical parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), total protein (TP), alkaline phosphatase (ALP), glucose (GLU), and creatine kinase (CK), were analyzed using an automatic biochemical analyzer (Hitachi 7020, Tokyo, Japan). Serum levels of total superoxide dismutase (T-SOD) and immunoglobulin G (IgG) were measured using a corresponding kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer's instructions.

Protein extraction and sample preparation {#Sec7}
-----------------------------------------

Small intestinal mucosa samples (500 μg) were ground in liquid nitrogen using a Dounce glass grinder. Grinded powder was precipitated with 10% trichloroacetic acid (TCA) (w/v) and 90% ice-cold acetone at −20 °C for 2 h. The precipitate was obtained by centrifugation at 20,000 g for 30 min at 4 °C and subsequently washed with ice-cold acetone. Then, the precipitate was lysed in lysis buffer \[8 M urea, 30 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1 mM phenylmethanesulfonyl fluoride (PMSF), 2 mM ethylene diamine tetraacetic acid (EDTA), and 10 mM dithiothreitol (DTT)\]. The crude tissue extracts were centrifuged to remove the remaining debris. The tissue lysates were reduced for 1 h at 56 °C in a water bath using 10 mM DTT and then alkylated with 55 mM iodoacetamide for 1 h in the dark. Afterwards, the lysates were precipitated by adding four volumes of pre-chilled acetone. The pellets were then washed three times with pre-chilled pure acetone and resuspended in the buffer (50% TEAB and 0.1% SDS). The centrifugation was repeated to remove the undissolved pellets. Subsequently, protein quantitation was determined using a Bio-Rad Bradford Protein Assay Kit (Hercules, CA, USA). Each sample was digested with modified sequence grade trypsin (Promega Corporation, Madison, WI) at a 1: 30 ratio (3.3 μg trypsin : 100 μg target) overnight at 37 °C. Each isobaric tag (113, 114, 115, 116, 117, 118, 119, and 121) was solubilized in 70 μL isopropanol and then added to each respective sample (4 samples per group). Incubation continued for 2 h at room temperature.

Strong cation exchange chromatography {#Sec8}
-------------------------------------

The strong cation exchange fractionation was performed according to a previous report \[[@CR26]\] with slight modification. Briefly, 800 μg of labeled sample was loaded onto a strong cation exchange column (Phenomenex Luna SCX 100A) installed in an Agilent 1100 (Santa Clara, CA) system and equilibrated with buffer A (25% acetonitrile and 10 mM KH~2~PO~4~, pH 3.0). The peptides were separated by a linear gradient of buffer B (25% acetonitrile, 2 M KCl and 10 mM KH~2~PO~4~, pH 3.0) according to this procedure (increasing to 5% after 41 min, 50% after 66 min and 100% after 71 min with a flow rate of 1 ml/min). Elution was monitored by setting the absorbance at 214 nm. A total of 10 fractions were obtained, then desalted with a Strata X C18 column (Phenomenex) and dried under a vacuum. The pellets were resuspended by adding 0.1% formic acid before the LC-MS/MS run.

Mass spectrometry {#Sec9}
-----------------

LC-MS/MS was conducted according to a previous report \[[@CR27]\], and the detailed process and parameters are shown in Additional file [1](#MOESM1){ref-type="media"}.

Data processing and protein quantification {#Sec10}
------------------------------------------

All the detailed parameters are shown in the Supporting Information (Additional file [1](#MOESM1){ref-type="media"}). MS/MS data for iTRAQ protein identification and quantitation were analyzed using Proteome Discover 1.3 (Thermo Fisher Scientific, Bremen, Germany) and in-house MASCOT software (Matrix Science, London, UK; Version 2.3.0) against the database Uniprot_pig (Apr. 11th, 2014). Median ratio normalization was performed in intra-sample channels to normalize each channel across all proteins. Protein quantitative ratios for each iTRAQ labeled sample were obtained, using a sample in the control group (sample tagged with 113) as the denominator. Quantitative ratios were then log transformed to base two and presented as the fold change relative to the denominator in the control group for final quantitative testing. Differentially expressed proteins were identified using Student's *t*-test corrected for multiple testing using the Benjamini and Hochberg correction \[[@CR21], [@CR25], [@CR28], [@CR29]\]. Based on above the relative quantification, statistical analysis, and a number of previous reports regarding to iTRAQ experiments \[[@CR29]--[@CR31]\], we set a 1.2-fold change or greater as the threshold for differentially expressed proteins.

Bioinformatics analysis and validation of protein expression {#Sec11}
------------------------------------------------------------

The databases and software for bioinformatics analysis are shown in Additional file [1](#MOESM1){ref-type="media"}. Real-time qPCR was used to verify six small intestinal mucosal proteins of differential abundance at the mRNA level. All detailed procedures are described in the Supporting Information (Additional file [1](#MOESM1){ref-type="media"}). The primer sequences used in this study are shown in Additional file [2](#MOESM2){ref-type="media"}: Table S1.

Statistical analysis {#Sec12}
--------------------

The data for growth parameters, serum parameters, and gene expression were analyzed by one-way ANOVA using block as a covariate (SAS Version 9.2, SAS institute Inc., Cary, NC) according the previous studies \[[@CR21], [@CR31]\], and a *t*-test was used for independent samples in MS data analysis. A group difference was assumed statistically significant when *P* \< 0.05.

Results {#Sec13}
=======

Growth performance of growing pigs {#Sec14}
----------------------------------

During the entire experimental period (50 days), NSPE pigs had 15.5% greater ADG (*P* \< 0.05) compared with the control group; however, the ADFI between the two groups was not significantly different (*P* \> 0.05). It is notable that pig fed NSPEs had an 8.7% greater FCR compared with the control group (*P* \< 0.05; Table [2](#Tab2){ref-type="table"}).Table 2Effects of NSP enzymes on growth performance of growing pigsGroupsControlTreatment*P* valueInitial weight (kg)38.80 ± 0.9939.55 ± 0.630.1245Final weight (kg)74.04 ± 1.77^b^78.42 ± 1.06^a^0.0318ADG (kg/d)^c^0.71 ± 0.05^b^0.82 ± 0.05^a^0.0437ADFI (kg/d)^d^1.97 ± 0.092.07 ± 0.060.0423FCR (kg feed/kg weight gain)^e^2.77 ± 0.02^a^2.53 ± 0.03^b^0.0352^a,\ b^ Values within a column having different superscript letters indicate a significant difference at *P* \< 0.05. Numbers are mean ± S.D. (*n* = 24 for ADG; *n* = 4 for ADFI and FCR)^c^ ADG = average daily gain^d^ ADFI = average daily feed intake^e^ FCR = feed conversion ratio

Serum parameters of growing pigs {#Sec15}
--------------------------------

In NSPE pigs, serum concentration of CK was significantly lower (*P* \< 0.05) than the control group (Table [3](#Tab3){ref-type="table"}). Furthermore, the serum concentrations of T-SOD, IgG, and glucose were significantly elevated compared with the control group (*P* \< 0.05) (Table [3](#Tab3){ref-type="table"}). Serum levels of TP, ALT and AST were similar between the two groups (Table [3](#Tab3){ref-type="table"}).Table 3Effect of NSPEs on serum biochemical parameters of growing pigsGroupsControlTreatment*P* valueALT (IU/L)^c^49.01 ± 7.9649.00 ± 9.300.4768AST (IU/L)^d^79.60 ± 10.7063.80 ± 16.050.2240TP (mmol/L)^e^67.31 ± 5.4469.50 ± 2.440.5331ALP (U/L)^f^131.83 ± 36.14126.40 ± 22.060.2565GLU (mmol/L)^g^6.37 ± 2.24^b^9.73 ± 2.34^a^0.0479T-SOD (U/mL)^h^61.55 ± 2.67^b^67.44 ± 3.64^a^0.0002CK (U/L)^i^3117 ± 274^a^2188 ± 218^b^0.0089IgG (g/L)^j^3.19 ± 0.16^b^3.43 ± 0.20^a^0.0392^a,\ b^Values within a column not sharing a common superscript letter indicate significant difference at *P* \< 0.05. Numbers are means ± S.D. (*n* = 4)^c^ALT = alanine aminotransferase^d^AST = aspartate aminotransferase^e^TP = total protein^f^ALP = alkaline phosphatase^g^GLU = glucose^h^T-SOD = total superoxide dismutase^i^CK = creatine kinase^j^IgG = immunoglobulin G

Identification and comparison of proteins of differential abundance {#Sec16}
-------------------------------------------------------------------

Using iTRAQ analysis, a total of 2634 proteins were identified within the FDR (false discovery rate) of 1% (Additional file [3](#MOESM3){ref-type="media"}: Table S2). Following statistical analysis, 104 proteins were found to be differentially expressed in the small intestinal mucosa between CTRL and NSPE pigs, with 43 up-regulated and 61 down-regulated (Additional file [4](#MOESM4){ref-type="media"}: Table S3).

A total of 90 proteins of differential abundance were grouped into eight classes based on putative functions: transcriptional and translational regulation (44.4%), miscellaneous (16.7%), redox homeostasis and detoxification (10.0%), immune response and inflammation (8.9%), energy metabolism (7.8%), protein metabolism and modification (5.6%), lipid metabolism (3.3%), and cell cytoskeleton (3.3%) (Fig. [1](#Fig1){ref-type="fig"}). Those related to transcriptional and translational regulation, redox homeostasis, and immune response were predominant, accounting for approximately 63% of the differentially expressed proteins. A comparison of proteins of differential abundance with functional groupings between the two groups indicated that a smaller number of protein species were up-regulated in NSPE pigs (36 versus 54) (Table [4](#Tab4){ref-type="table"}).Fig. 1Functional classification of the proteins of differential abundance identified from the small intestinal mucosa of growing pigs supplemented with NSPE Table 4List of differentially expressed proteins in small intestinal mucosal samples from treatment group and control groupAccession^a^Description^b^Gene symbolScore^c^Pep. No^d^Log~2~ fold change*P*-value^e^Biological process GO termTranscriptional and translational regulation F1S419Uncharacterized protein OS = Sus scrofa GN = SF3B3 PE = 4 SV = 2 - \[F1S419_PIG\]None85.613−0.370.0007RNA binding K9J4V0U5 small nuclear ribonucleoprotein 200 kDa helicase OS = Sus scrofa GN = SNRNP200 PE = 2 SV = 1 - \[K9J4V0_PIG\]SNRNP200248.189−0.320.0012Nucleic acid binding F2Z5Q640S ribosomal protein S6 (Fragment) OS = Sus scrofa GN = RPS6 PE = 3 SV = 2 - \[F2Z5Q6_PIG\]RPS6140.424−0.810.0013Structural constituent of ribosome F1SD96Uncharacterized protein (Fragment) OS = Sus scrofa GN = RAD23A PE = 4 SV = 1 - \[F1SD96_PIG\]RAD23A85.2531.060.0026Nucleotide excision repair F1S8K5Uncharacterized protein OS = Sus scrofa GN = SUPT16H PE = 4 SV = 1 - \[F1S8K5_PIG\]SUPT16H35.432−0.400.0028RNA binding F1RZH4Uncharacterized protein OS = Sus scrofa PE = 4 SV = 1 - \[F1RZH4_PIG\]ADAM1032.671−0.820.0048Structural constituent of ribosome F1SD98Uncharacterized protein OS = Sus scrofa GN = TRMT1 PE = 4 SV = 2 - \[F1SD98_PIG\]TRMT127.721−0.300.0065Poly(A) RNA binding I3LHZ6Uncharacterized protein OS = Sus scrofa GN = DHX9 PE = 4 SV = 1 - \[I3LHZ6_PIG\]DHX9994.7127−0.300.0075ATP-dependent RNA helicase activity F1SDV7Uncharacterized protein (Fragment) OS = Sus scrofa GN = TOP1 PE = 4 SV = 1 - \[F1SDV7_PIG\]TOP199.934−0.440.0075DNA binding P62802Histone H4 OS = Sus scrofa PE = 1 SV = 2 - \[H4_PIG\]None358.117−0.670.0103DNA binding F1S1V1Uncharacterized protein OS = Sus scrofa GN = SSB PE = 4 SV = 2 - \[F1S1V1_PIG\]SSB196.56−0.730.0111Nucleotide binding F1RS45DNA topoisomerase 2 OS = Sus scrofa PE = 3 SV = 2 - \[F1RS45_PIG\]TOP2B116.626−0.270.0117DNA binding F1S1X3Uncharacterized protein OS = Sus scrofa GN = NARS PE = 3 SV = 2 - \[F1S1X3_PIG\]NARS262.657−0.300.0119Nucleotide binding F2Z576Histone H3 OS = Sus scrofa GN = LOC100525821 PE = 2 SV = 1 - \[F2Z576_PIG\]HIST1H3E159.446−0.770.0120DNA binding Q29194Ribosomal protein S2 (Fragment) OS = Sus scrofa PE = 2 SV = 1 - \[Q29194_PIG\]None46.591−0.450.0138Structural constituent of ribosome I3LFV4Uncharacterized protein OS = Sus scrofa GN = YBX1 PE = 4 SV = 1 - \[I3LFV4_PIG\]YBX1157.8940.410.0148DNA repair I3LIN8Histone H2A OS = Sus scrofa GN = H2AFY PE = 3 SV = 1 - \[I3LIN8_PIG\]H2AFY224.896−0.520.0149Chromatin DNA binding B0FWK5Ribosomal protein L5 OS = Sus scrofa GN = RPL5 PE = 2 SV = 1 - \[B0FWK5_PIG\]RPL5178.578−0.340.0165Structural constituent of ribosome I3LCI4Uncharacterized protein OS = Sus scrofa GN = ZFR PE = 4 SV = 1 - \[I3LCI4_PIG\]ZFR41.932−0.280.0167Poly(A) RNA binding F1S8A5Uncharacterized protein OS = Sus scrofa GN = MRPS26 PE = 4 SV = 1 - \[F1S8A5_PIG\]MRPS2638.631−0.360.0181Poly(A) RNA binding A5GFY4Negative elongation factor D OS = Sus scrofa GN = NELFCD PE = 3 SV = 1 - \[NELFD_PIG\]NELFCD43.671−0.320.0189Negative regulation of transcription F1S5A8Uncharacterized protein OS = Sus scrofa GN = DHX15 PE = 4 SV = 1 - \[F1S5A8_PIG\]DHX15259.438−0.260.0198ATP-dependent RNA helicase activity F1RRG9Uncharacterized protein OS = Sus scrofa GN = SMARCA5 PE = 4 SV = 1 - \[F1RRG9_PIG\]SMARCA599.443−0.390.0201DNA binding F1RGP1Uncharacterized protein OS = Sus scrofa GN = MYBBP1A PE = 4 SV = 1 - \[F1RGP1_PIG\]MYBBP1A445.8912−0.500.0208Poly(A) RNA binding F2Z5Q8Uncharacterized protein OS = Sus scrofa GN = LOC100519675 PE = 4 SV = 1 - \[F2Z5Q8_PIG\]RPL35A57.332−0.450.0209Structural constituent of ribosome I3L7T6Histone H2A OS = Sus scrofa GN = H2AFX PE = 3 SV = 1 - \[I3L7T6_PIG\]H2AFX357.77−0.560.0231DNA binding F1SMZ9Uncharacterized protein (Fragment) OS = Sus scrofa GN = SF3B1 PE = 4 SV = 2 - \[F1SMZ9_PIG\]SF3B1267.339−0.260.0245mRNA binding F2Z5K9Histone H3 OS = Sus scrofa GN = LOC100622412 PE = 3 SV = 1 - \[F2Z5K9_PIG\]LOC100622412178.756−0.760.0270DNA binding P5302760S ribosomal protein L10a (Fragment) OS = Sus scrofa GN = RPL10A PE = 2 SV = 3 - \[RL10A_PIG\]RPL10A154.255−0.340.0272RNA binding K9IVG8DEAD (Asp-Glu-Ala-Asp) box helicase 21 OS = Sus scrofa GN = DDX21 PE = 2 SV = 1 - \[K9IVG8_PIG\]DDX2144.621−0.380.0292RNA binding F2Z554Uncharacterized protein OS = Sus scrofa GN = RPL30 PE = 3 SV = 1 - \[F2Z554_PIG\]RPL30105.874−0.260.0323RNA binding Q2919560S ribosomal protein L10 OS = Sus scrofa GN = RPL10 PE = 2 SV = 3 - \[RL10_PIG\]RPL10105.84−0.390.0350Structural constituent of ribosome P6798560S ribosomal protein L22 OS = Sus scrofa GN = RPL22 PE = 2 SV = 2 - \[RL22_PIG\]RPL22113.833−0.480.0355Structural constituent of ribosome I7GF95Guanine nucleotide binding protein-like 1 OS = Sus scrofa GN = GNL1 PE = 4 SV = 1 - \[I7GF95_PIG\]GNL158.561−0.350.0371Ribosome biogenesis F1S8L9Uncharacterized protein OS = Sus scrofa GN = HNRNPU PE = 4 SV = 2 - \[F1S8L9_PIG\]HNRNPU883.6123−0.340.0377Poly(A) RNA binding Q53DY5Histone H1.3-like protein OS = Sus scrofa GN = LOC595122 PE = 2 SV = 1 - \[Q53DY5_PIG\]HIST1H1D251.9271.290.0384Chromatin DNA binding F1S2G3Uncharacterized protein (Fragment) OS = Sus scrofa GN = TBCA PE = 4 SV = 1 - \[F1S2G3_PIG\]TBCA78.1820.310.0389Poly(A) RNA binding F2Z5P1Histone H2A (Fragment) OS = Sus scrofa GN = H2AFV PE = 3 SV = 1 - \[F2Z5P1_PIG\]LOC100512448256.745−0.430.0427DNA binding F2Z553Uncharacterized protein OS = Sus scrofa GN = EIF1 PE = 4 SV = 1 - \[F2Z553_PIG\]EIF1103.6620.820.0437Translation initiation factor activity F2Z5L5Histone H2A OS = Sus scrofa GN = HIST2H2AC PE = 3 SV = 1 - \[F2Z5L5_PIG\]HIST2H2AC322.15−0.620.0448DNA bindingRedox homeostasis and detoxification F1SKJ2Uncharacterized protein OS = Sus scrofa GN = TXN2 PE = 4 SV = 1 - \[F1SKJ2_PIG\]TXN229.8610.390.0043Cell redox homeostasis F1SGS9Catalase OS = Sus scrofa GN = CAT PE = 3 SV = 1 - \[F1SGS9_PIG\]CAT923.56230.580.0151Protect cells from the toxic effects of hydrogen peroxide I3LDJ8Uncharacterized protein OS = Sus scrofa PE = 3 SV = 1 - \[I3LDJ8_PIG\]None303.51100.770.0202Oxidoreductase activity P12309Glutaredoxin-1 OS = Sus scrofa GN = GLRX PE = 1 SV = 2 - \[GLRX1_PIG\]GLRX277.8360.640.0208Cell redox homeostasis F1SCF9Uncharacterized protein (Fragment) OS = Sus scrofa GN = TECR PE = 4 SV = 2 - \[F1SCF9_PIG\]TECR38.341−0.370.0242Oxidoreductase activity A5J2A8Thioredoxin (Fragment) OS = Sus scrofa GN = TRX PE = 4 SV = 1 - \[A5J2A8_PIG\]TRX128.3630.340.0303Cell redox homeostasis F1SMY1Uncharacterized protein OS = Sus scrofa GN = TMX3 PE = 4 SV = 2 - \[F1SMY1_PIG\]TMX339.120.300.0345Cell redox homeostasis P16549Dimethylaniline monooxygenase \[N-oxide-forming\] 1 OS = Sus scrofa GN = FMO1 PE = 1 SV = 3 - \[FMO1_PIG\]FMO139.5521.640.0084Oxidative metabolism of a variety of xenobiotics P04178Superoxide dismutase \[Cu-Zn\] OS = Sus scrofa GN = SOD1 PE = 1 SV = 2 - \[SODC_PIG\]SOD1459.0490.350.0424Superoxide dismutase activityImmune response and inflammation A3FJ41MHC class I antigen (Fragment) OS = Sus scrofa GN = SLA-1 PE = 4 SV = 1 - \[A3FJ41_PIG\]SLA-1120.0350.350.0050Immune response F1RGC8Uncharacterized protein OS = Sus scrofa GN = NLRP6 PE = 4 SV = 3 - \[F1RGC8_PIG\]NLRP6119.584−0.320.0061Activation of NF-κB F1RFM7Uncharacterized protein OS = Sus scrofa GN = AIMP2 PE = 4 SV = 1 - \[F1RFM7_PIG\]AIMP2232.756−0.290.0076Metabolism of xenobiotics A2SZV5Tax1 binding protein 3 (Fragment) OS = Sus scrofa PE = 4 SV = 1 - \[A2SZV5_PIG\]None55.1410.290.0133Negative regulation of NF-κB B8XX91DNA-dependent activator of IFN-regulatory factor OS = Sus scrofa GN = DAI PE = 2 SV = 1 - \[B8XX91_PIG\]DAI100.540.700.0137Innate immune responses Q8WNQ7N-acetylgalactosamine-6-sulfatase OS = Sus scrofa GN = GALNS PE = 2 SV = 1 - \[GALNS_PIG\]GALNS52.5210.600.0311Degradation of the glycosaminoglycans keratan sulfate B8XTR8Granzyme H OS = Sus scrofa GN = gzmH PE = 2 SV = 1 - \[B8XTR8_PIG\]gzmH168.846−0.670.0272Serine-type endopeptidase activity A5GFQ5Protein canopy homolog 3 OS = Sus scrofa GN = CNPY3 PE = 3 SV = 1 - \[CNPY3_PIG\]CNPY340.132−0.630.0376Receptor binding for proper TLR foldingEnergy metabolism Q1ACV5Transporter associated with antigen processing 1 OS = Sus scrofa PE = 2 SV = 1 - \[Q1ACV5_PIG\]None298.677−0.320.0030Triggers ATP hydrolysis F1RIG0Uncharacterized protein (Fragment) OS = Sus scrofa PE = 4 SV = 1 - \[F1RIG0_PIG\]None47.282−0.270.0169ATP binding Q7SIB7Phosphoglycerate kinase 1 OS = Sus scrofa GN = PGK1 PE = 1 SV = 3 - \[PGK1_PIG\]PGK1850.39230.300.0160Conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate H9BYW2Acyl-coenzyme A oxidase OS = Sus scrofa GN = ACOX1 PE = 2 SV = 1 - \[H9BYW2_PIG\]ACOX1370.35100.910.0200Fatty acid beta-oxidation I3LEN7Uncharacterized protein OS = Sus scrofa GN = ALDH1L1 PE = 3 SV = 1 - \[I3LEN7_PIG\]ALDH1L149.0420.400.0245Formate oxidation F1S0Y8Uncharacterized protein OS = Sus scrofa GN = ADH4 PE = 3 SV = 2 - \[F1S0Y8_PIG\]ADH440.720.670.0309Oxidation of long-chain aliphatic alcohols A7UIU7ATP citrate lyase OS = Sus scrofa GN = ACL PE = 2 SV = 1 - \[A7UIU7_PIG\]ACL468.9814−0.380.0374ATP bindingProtein metabolism and modification F1RIF3Uncharacterized protein OS = Sus scrofa GN = FAH PE = 4 SV = 1 - \[F1RIF3_PIG\]FAH38.3720.390.0010Catabolism of the amino acid phenylalanine Q9GK25Peptidyl-prolyl cis-trans isomerase (Fragment) OS = Sus scrofa PE = 2 SV = 1 - \[Q9GK25_PIG\]None266.171.430.0025Accelerate the folding of proteins I3L739Uncharacterized protein OS = Sus scrofa GN = JMJD6 PE = 4 SV = 1 - \[I3L739_PIG\]JMJD639.991−0.290.0193Protein hydroxylases I3LK37Uncharacterized protein (Fragment) OS = Sus scrofa PE = 3 SV = 1 - \[I3LK37_PIG\]GALNT733.392−0.300.0248Protein glycosylation F1RNR64-hydroxyphenylpyruvate dioxygenase OS = Sus scrofa GN = HPD PE = 3 SV = 2 - \[F1RNR6_PIG\]HPD3110.350.0391Aromatic amino acid family metabolic processLipid metabolism I3LM15Uncharacterized protein OS = Sus scrofa GN = AGPS PE = 4 SV = 1 - \[I3LM15_PIG\]AGPS48.771−0.360.0019Lipid biosynthetic process Q9GJX2Diazepam binding inhibitor (Fragment) OS = Sus scrofa GN = DBI PE = 2 SV = 1 - \[Q9GJX2_PIG\]DBI80.1330.910.0057Long-chain fatty acyl-CoA binding, triglyceride metabolic process P27917Apolipoprotein C-III OS = Sus scrofa GN = APOC3 PE = 1 SV = 2 - \[APOC3_PIG\]APOC3226.3970.780.0241High-density lipoprotein particle receptor bindingCell cytoskeleton P10668Cofilin-1 OS = Sus scrofa GN = CFL1 PE = 1 SV = 3 - \[COF1_PIG\]CFL1704.02150.310.0059Cytoskeleton organization Q5G6W0Cofilin-2 (Fragment) OS = Sus scrofa PE = 2 SV = 1 - \[Q5G6W0_PIG\]CFL148.6720.430.0073Cytoskeleton organization B5APV0Actin-related protein 2/3 complex subunit 5 OS = Sus scrofa GN = ARPC5 PE = 2 SV = 1 - \[B5APV0_PIG\]ARPC5170.9960.300.0167Structural constituent of cytoskeletonMiscellaneous Q9TSA7Calmodulin (Fragments) OS = Sus scrofa PE = 4 SV = 1 - \[Q9TSA7_PIG\]None108.7241.110.0008Calcium ion binding K7GKQ1Uncharacterized protein OS = Sus scrofa GN = RAB9A PE = 3 SV = 1 - \[K7GKQ1_PIG\]RAB9A26.61−0.400.0071Cytoskeletal signaling F1RKI3Uncharacterized protein OS = Sus scrofa GN = HINT1 PE = 4 SV = 1 - \[F1RKI3_PIG\]HINT180.5530.320.0073Tumor suppressing I3LSY0Uncharacterized protein OS = Sus scrofa GN = ACSM4 PE = 4 SV = 1 - \[I3LSY0_PIG\]ACSM421.1310.860.0179Catalytic activity D0G6R8Phosphatidate cytidylyltransferase OS = Sus scrofa GN = CDS2 PE = 2 SV = 1 - \[D0G6R8_PIG\]CDS233.011−0.390.0192Synthesis of phosphatidylglycerol Q95332Betaine\--homocysteine S-methyltransferase 1 (Fragment) OS = Sus scrofa GN = BHMT PE = 1 SV = 3 - \[BHMT1_PIG\]BHMT110.4141.100.0193Regulation of homocysteine metabolism F1RS34Uncharacterized protein OS = Sus scrofa GN = GAPVD1 PE = 4 SV = 2 - \[F1RS34_PIG\]GAPVD122.691−0.400.0207Signal transduction F1ST01Uncharacterized protein OS = Sus scrofa GN = SELENBP1 PE = 4 SV = 1 - \[F1ST01_PIG\]SELENBP1936.42220.330.0209Selenium binding Q9TV62Myosin-4 OS = Sus scrofa GN = MYH4 PE = 2 SV = 1 - \[MYH4_PIG\]MYH4192.947−0.830.0336Motor activity F1RN91Uncharacterized protein (Fragment) OS = Sus scrofa PE = 4 SV = 2 - \[F1RN91_PIG\]MYO18A35.0420.280.0355Cell migration F1RPC8Uncharacterized protein OS = Sus scrofa GN = CRYM PE = 4 SV = 2 - \[F1RPC8_PIG\]CRYM59.3320.490.0392Thyroid hormone binding F2Z5W6Uncharacterized protein OS = Sus scrofa GN = LAMTOR1 PE = 4 SV = 1 - \[F2Z5W6_PIG\]LAMTOR126.541−0.370.0410Guanyl-nucleotide exchange factor activity Q29069Myosin light chain OS = Sus scrofa PE = 2 SV = 2 - \[Q29069_PIG\]None58.613−0.380.0458Calcium ion binding O19175Casein kinase I isoform alpha (Fragment) OS = Sus scrofa GN = CSNK1A1 PE = 2 SV = 1 - \[KC1A_PIG\]CSNK1A151.131−0.440.0473Protein kinase activity N0E654Casein kinase II b subunit splicing isoform 476 (Fragment) OS = Sus scrofa GN = Csnk2b PE = 2 SV = 1 - \[N0E654_PIG\]Csnk2b63.972−0.270.0039Cell proliferation and cell differentiation^a^Uniprot\_ Sus scrofa_9823 database accession number^b^The name of the protein exclusive of the identifier that appears in the database^c^The sum of the scores of the individual peptides^d^The number of distinct peptide sequences in the protein group^e^Differential protein expression in the treatment group was presented as a log~2~ fold change relative to the control group

GO annotations of proteins of differential abundance {#Sec17}
----------------------------------------------------

In the cellular component group, the differentially expressed proteins were concentrated in the intracellular part and membrane-bounded organelles (Fig. [2](#Fig2){ref-type="fig"}). In the molecular functional group, the differentially expressed proteins that are binding proteins (protein, nucleotide, or nucleic acid binding) and metabolic enzymes (hydrolase, oxidoreductase, or transferase activity) were ranked at the top of the category (Fig. [2](#Fig2){ref-type="fig"}). In the biological process category, the proteins that participate in cellular process (organelle organization process), metabolic process (nitrogen compound metabolic and biosynthetic process), and biological regulation (transcriptional and translational regulation, redox homeostasis, and immune response) had the highest ratios among the differentially expressed proteins.Fig. 2GO distribution analysis of differentially expressed proteins in small intestinal mucosal samples from the NSPE group and control group. The right coordinate axis indicates the number of proteins for each GO annotation, and the left one represents the proportion of proteins for every GO annotation

Validation of proteins of differential abundance {#Sec18}
------------------------------------------------

Six differentially expressed proteins superoxide dismutase (SOD1) involved in redox homeostasis; calmodulin (CALM1) involved in calcium ion binding; MHC class I antigen (SLA-1) involved in immune response; acyl-coenzyme A oxidase (ACOX1) involved in energy metabolism; 40S ribosomal protein S6 (RPS6) involved in transcriptional and translational regulation; and apolipoprotein C-III (APOC3) involved in lipid absorption, were selected for the validation of proteomic data at the mRNA level using qPCR (Fig. [3](#Fig3){ref-type="fig"}). Most protein levels were consistent with their mRNA expression levels, except for RPS6.Fig. 3qPCR validation of six proteins of differential abundance from the intestinal mucosa of growing pigs at the mRNA level (**a**, **b**, **c**, **d**, **e** and **f**). Samples were normalized with the reference gene β-actin. Vertical lines represent means ± S.D, and different letters denote significant difference at *P* \< 0.05 (*n* = 4)

Discussion {#Sec19}
==========

The benefit of NSPEs supplementation is well recognized in monogastric animal production; NSPEs supplementation promotes growth performance and GI tract health, including the efficiency of nutrient utilization \[[@CR2], [@CR3], [@CR8]\]. A number of studies have proven that the addtion of NSPEs to the diet reduces digesta viscosity by the partial or complete hydrolysis of soluble NSPs, which triggers the changes in microbial composition, especially the reduction of the amount of pathological bacteria within the small intestine \[[@CR11], [@CR32]\]. Moreover, the supplementation of NSPEs could increase the nutrient availability in the intestinal lumen (for example, energy substrates and proteins) \[[@CR12], [@CR33]\]. All above effects of NSPE supplementation are due to the improvements of the intestinal environment. However, it is still largely unknown how the small intestinal mucosa of the hosts responds to alterations in the luminal environment triggered by the addition of NSPEs. The present study marks the first time that the well-established quantitative iTRAQ label-based technology was applied for the proteomic analysis of the small intestinal mucosa of growing pigs with dietary supplementation of NSPEs. Various functional groupings of differentially expressed mucosal proteins related to nutrient metabolism, transcriptional and translational regulation, immune, and redox homeostasis were identified in response to NSPEs.

In former research, the utilization of β-glucanase and xylanase in the diet demonstrated that enzymes tended to increase the absorptive area and reduce cell proliferation and intraepithelial lymphocytes in the gut of pigs \[[@CR34]\]. Both cereal grains and enzymes would affect components of gut health, including intestine morphology, bacteria populations, and microbial metabolites in the gut content \[[@CR35]\]. It has been demonstrated that enhanced cell proliferation in the intestinal mucosa is associated with bowel diseases, cellular repair, and apoptosis \[[@CR36], [@CR37]\]. As shown in the present study, 89% of proteins related to transcriptional and translational regulation were down-regulated in NSPE pigs. We speculate that supplementation with NSPEs in the diet of growing pigs can reduce the possibility of intestinal infection. This is consistent with the former research result that NSPEs reduce the amount of pathological bacteria within the small intestine by lowering the viscosity of intestinal digesta \[[@CR11]\].

The abundance of proteins CFL1 (cofilin-1), CFL2 (cofilin-2) and ARPC5 (actin-related protein 2/3 complex subunit 5), which are classified as cell cytoskeleton proteins relevant to cell structure and mobility, was increased. CFL1 and CFL2 are widely distributed intracellular actin-modulating proteins \[[@CR38]\]. These two proteins can cause actin cytoskeleton rearrangement and membrane remodeling to the formation of phagosomes, which are recognized by Fc gamma receptors and beneficial for the host-defense in animals \[[@CR39]\]. ARPC5 has a similar function as cofilin in the actin cytoskeleton, which is required for phagocytosis in mammals \[[@CR40]\]. The up-regulation of these proteins might reflect the improved integrity of the intestinal mucosa.

As an important immune organ, the small intestine participates in the inflammatory response and the prevention of bacterial infection. SLA-1 (MHC class I antigen), GALNS (N-acetylgalactosamine-6-sulfatase), and DAI (DNA-dependent activator of IFN-regulatory factor) are considered to be involved in the immune response. SLA-1 alerts the immune system to virus-infected cells by presenting peptide fragments derived from intracellular proteins \[[@CR41]\]. GALNS is located in lysosomes that digest different types of molecules and engulf viruses or bacteria within cells \[[@CR42], [@CR43]\]. DAI selectively enhances the DNA-mediated induction of type I IFN and other genes involved in innate immunity \[[@CR44], [@CR45]\]. The abundance of these proteins was up-regulated in NSPE pigs, suggesting that the supplementation of NSPEs may improve potential immunity and reduce the chance of bacterial infection in the small intestine. This is consistent with the elevated serum level of IgG in the NSPE group. However, challenges with exogenous pathogens are still required to verify the effect of NSPEs supplementation on immunity. In contrast, proteins involved in an inflammatory response, including NLRP6 (NLR family, pyrin domain containing 6) and CNPY3 (protein canopy homolog 3), are down-regulated, which indicates that inflammation is attenuated in the small intestinal mucosa due to the supplementation of NSPEs \[[@CR46]\]. It has been suggested that one of the performance improvement attributes of NSPEs is due to the reduced local inflammation by controlling pathogens within the small intestine \[[@CR32]\].

In addition to affecting the immune response, the up-regulated proteins catalase (CAT), glutaredoxin (GRXS), thioredoxin (TRX), superoxide dismutase (SOD), dimethylaniline monooxygenase \[N-oxide-forming\] 1 (FMO1) and 4-hydroxyphenylpyruvate dioxygenase (HPPD) are classified as redox homeostasis and detoxification proteins based on their primary functions. The up-regulation of CAT, GRXS, TRX and SOD may suggest that NSPE pigs had more potential to keep redox homeostasis in vivo \[[@CR47]--[@CR52]\]. This is consistent with the increased serum level of T-SOD in the NSPE group of this study. The reason for the up-regulation of these oxidoreductases and immune factors in the present study may be the increased abundance of reactive oxygen species (ROS) and inflammatory factors during stimulating energy metabolism due to a higher uptake of nutrients with NSPEs supplementation. However, further study is required to prove the effect of NSPEs on redox homeostasis. As one of the detoxification enzymes, FMO1 is regulated by xenobiotics, as the enzyme activity markedly increases in response to the invading harmful chemicals \[[@CR53]\]. The up-regulation of this protein suggests that the supplementation of NSPEs is helpful to eliminate xenobiotics in the small intestine, which also could be related to the improvement of the intestinal lumen due to NSPEs.

Furthermore, the up-regulated abundance of proteins was observed in the NSPE group, including multiple nutrient metabolism processes such as energy, lipid, amino acid and mineral. These proteins included phosphoglycerate kinase 1 (PGK1), diazepam binding inhibitor (DBI), and acyl-coenzyme A oxidase (ACOX1). PGK1 plays a vital role in glycolysis or gluconeogenesis \[[@CR54]\]. The up-regulation of ACOX1 indicates the elevation of glucose synthesis in the small intestine, which is consistent with the increased serum glucose level in the NSPE group. Likewise, higher abundance of DBI and ACOX1 was observed in this study, suggesting the stimulation of lipids β-oxidation for nutrient absorption to meet the energy requirement in the small intestine of NSPE pigs \[[@CR55], [@CR56]\]. Apolipoprotein C-III (APOC3) is an important modulator that is secreted from the intestine on the chylomicron upon lipid absorption \[[@CR57]\]. The up-regulation of APOC3 implies the enhanced absorption of dietary lipids in the NSPE group.

Two differentially expressed proteins related to the permeability of the tight junction (TJ), including casein kinase II beta subunit splicing isoform 476 (Csnk2b) and myosin-4 (MYH4), were identified in the present study. The tight junctions (TJs) in the small intestine are not only a physical and biological barrier but also a passive diffusion system that depends on the permeability of the TJs \[[@CR58]\]. Paracellular transport is one of the passive diffusion systems providing an absorption way for small molecular compounds \[[@CR59]\], which are regulated by the permeability of the TJs and are thought to be important for mineral absorption \[[@CR60]\]. Additionally, the transepithelial transport of oligosaccharides, but not polysaccharides, also occurs *via* the paracellular pathway \[[@CR61]\]. Previous research has demonstrated that NSPEs are capable of hydrolyzing polysaccharides from the food to oligosaccharides in the gut \[[@CR62]\]. Thus, the down-regulation of these two proteins in this study, in addition to former studies, indicates an increased permeability of the TJs in the NSPE group, which is beneficial to small molecular compounds absorption in the small intestine.

Calmodulin regulates cellular calcium concentration as a primary calcium-binding protein \[[@CR63]\]. Calcium absorption is reduced if the bioavailability of dietary calcium is lowered by calcium-binding agents like cellulose because nearly all dietary calcium intake occurs in the upper intestine \[[@CR64]\]. The up-regulation of this protein observed in this study suggests that calcium absorption in the small intestine is facilitated in the NSPE group by the degradation of calcium-binding agents in the diet, which could be conductive to bone health.

It has been demonstrated that one of the important roles of NSPEs within the small intestine is the elimination of the nutrient-encapsulating effect of cell wall polysaccharides, which increases the availability of starches, amino acids, and minerals. These results are consistent with our results from the present study that the levels of proteins related to nutrient absorption and utilization (energy, lipid, amino acid and mineral) are up-regulated. A fully understanding of the mechanisms of NSPEs supplementation will require the determination of protein modifications and protein regulation such as phosphorylation or glycosylation \[[@CR65]\]. However, this part was not involved in the present study due to the technical limitation. Thus, further study is required to prove the effect of NSPEs on regulatory proteins using specific method, for example, the phosphoproteome.

Conclusions {#Sec20}
===========

The results of this study provide the first evidence that the small intestinal mucosa proteome is altered in growing pigs supplemented with NSPEs. Growing pigs most likely responded to the increased reactive oxygen species (ROS) and inflammatory factors during stimulating energy metabolism due to NSPEs supplementation by changing the abundance of certain mucosal proteins that modulate redox homeostasis and enhance immune response. Most important of all, the effect of NSPEs on the increase of nutrient availability in the intestinal lumen provided additional benefits to facilitate protein expressions related to the efficiency of nutrient absorption and utilization, such as energy metabolism, amino acid metabolism, mineral metabolism, lipid absorption, and cell structure and mobility. These novel findings show the mechanisms whereby dietary supplementation with NSPEs promotes growth performance and improves the GI health of growing pigs, which also has important implications for the better utilization of this feed additive.
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